Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rafi Kabarriti
AIDS Malignancy Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Zuckerberg San Francisco General Hospital
San Francisco, California, United States
- George Washington University Medical Center
Washington D.C., District of Columbia, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- University of Illinois
Chicago, Illinois, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Mount Sinai Hospital
New York, New York, United States
- Mount Sinai West
New York, New York, United States
- Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
- Montefiore Medical Center-Einstein Campus
The Bronx, New York, United States
- Pennsylvania Hospital
Philadelphia, Pennsylvania, United States
- Lyndon Baines Johnson General Hospital
Houston, Texas, United States
- Ut Md Anderson Cancer Center
Houston, Texas, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Aug 2022
- Primary completion
- 15 Sept 2031
- Completion
- 15 Sept 2031
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 40
- Registry id
- NCT04929028
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.